{"filings":[{"id":93674,"accession_number":"0001437749-26-013677","cik":1563665,"company_name":"Harvard Apparatus Regenerative Technology, Inc.","ticker":"HRGN","form_type":"8-K","filed_at":"2026-04-28T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Harvard Apparatus Regenerative Technology treats first patient in Phase 1 esophageal implant trial","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["First patient treated with Cellspan Esophageal Implant (CEI) in Phase 1 clinical trial at Mayo Clinic.","Phase 1 trial is a feasibility and safety study in up to 10 patients under an FDA-approved IND, with three active clinical sites.","Primary endpoint: establishment of a continuous biological neoconduit by three months post-surgery; secondary: mucosal lining by 12 months.","CEI combines a polyurethane scaffold with autologous adipose-derived mesenchymal stromal cells; scaffold removed endoscopically at 21-42 days."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":23030772.999999996,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":93673,"accession_number":"0001437749-26-012380","cik":1563665,"company_name":"Harvard Apparatus Regenerative Technology, Inc.","ticker":"HRGN","form_type":"8-K","filed_at":"2026-04-15T23:59:59+00:00","items":["1.02","9.01"],"status":"ready","headline":"Harvard Apparatus receives $300K bridge loan from CEO Junli He at 8% interest","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Loan of $300,000 from Chairman/CEO Junli He; annual 8% fixed interest rate.","Matures on earlier of closing of $5M+ capital raise or April 13, 2027.","Lender may optionally convert principal and accrued interest into equity at next qualified financing.","Related-party transaction filed under Item 1.02; note contains customary events of default.","Company trades on OTCQB under ticker HRGN."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":23030772.999999996,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":105492,"accession_number":"0001437749-26-000452","cik":1563665,"company_name":"Harvard Apparatus Regenerative Technology, Inc.","ticker":"HRGN","form_type":"8-K","filed_at":"2026-01-06T23:59:59+00:00","items":["1.01","3.02","9.01"],"status":"ready","headline":"Harvard Apparatus Regenerative Technology raises ~$0.7M in private placement of 411,765 shares at $1.70/share","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Sold 411,765 shares of common stock at $1.70 per share for aggregate proceeds of approximately $0.7 million.","Private placement exempt under Section 4(a)(2) and Rule 506; securities not registered.","Purchase agreements effective December 30, 2025; no use of proceeds disclosed."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":23030772.999999996,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":138440,"accession_number":"0001437749-25-022650","cik":1563665,"company_name":"Harvard Apparatus Regenerative Technology, Inc.","ticker":"HRGN","form_type":"8-K","filed_at":"2025-07-14T23:59:59+00:00","items":["1.01","3.02","9.01"],"status":"ready","headline":"Harvard Apparatus raises $2.0M via private placement of 1.25M shares at $1.60/share","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Sold 1,250,000 shares of common stock to accredited investors for aggregate proceeds of ~$2.0M.","Per-share purchase price of $1.60; closing occurred on July 11, 2025.","Shares issued in reliance on Section 4(a)(2) and Rule 506 exemption from registration.","Customary representations, warranties and covenants in the Securities Purchase Agreement."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":23030772.999999996,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":155902,"accession_number":"0001437749-25-021097","cik":1563665,"company_name":"Harvard Apparatus Regenerative Technology, Inc.","ticker":"HRGN","form_type":"8-K","filed_at":"2025-06-24T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Harvard Apparatus shareholders approve reverse stock split and declassification amendment at annual meeting","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Reverse stock split amendment approved; Board authorized to determine ratio and timing at discretion.","Declassification amendment eliminates staggered board; special meetings can be called by holders of at least 35% voting power.","Directors Jason Chen and Herman Sanchez elected as Class III directors with 12.7M and 8.3M votes for, respectively.","Ratification of CBIZ CPAs as auditor for FY2025 passed with 14.4M for, 28K against; say-on-pay advisory vote passed.","All proposals passed with strong shareholder support; broker non-votes reported for most items."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":23030772.999999996,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":155901,"accession_number":"0001437749-25-011884","cik":1563665,"company_name":"Harvard Apparatus Regenerative Technology, Inc.","ticker":"HRGN","form_type":"8-K","filed_at":"2025-04-14T23:59:59+00:00","items":["4.01","9.01"],"status":"ready","headline":"Harvard Apparatus Regenerative Tech replaces auditor: Marcum resigns, CBIZ CPAs P.C appointed April 11, 2025","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Marcum LLP resigned as independent auditor effective April 11, 2025; Audit Committee approved CBIZ CPAs P.C. as successor the same day.","No disagreements with Marcum on accounting principles, disclosure, or audit scope during fiscal 2023, 2024, or through April 14, 2025.","Marcum's reports for fiscal 2023 and 2024 were unqualified but included a going-concern explanatory paragraph.","Marcum's letter concurring with disclosure is filed as Exhibit 16.1."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":23030772.999999996,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":191307,"accession_number":"0001493152-24-043862","cik":1563665,"company_name":"Harvard Apparatus Regenerative Technology, Inc.","ticker":"HRGN","form_type":"8-K","filed_at":"2024-11-06T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Harvard Apparatus Regenerative Technology signs exclusive global distribution deal with Health Regen through 2030","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Exclusive distribution of consumer health/dietary supplements from Nov 1, 2024 to Dec 31, 2030; auto-renews for 6 years if targets met.","Annual sales targets: $1M (2025) escalating to $20M (2030); Company receives 10% markup on manufacturing costs plus pass-through costs.","Early termination by Company triggers penalty of 3x projected annual sales in year 6.","Chinese subsidiary employees and inventory to be transferred to Health Regen effective Nov 1, 2024."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":23030772.999999996,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":207789,"accession_number":"0001493152-24-034014","cik":1563665,"company_name":"Harvard Apparatus Regenerative Technology, Inc.","ticker":"HRGN","form_type":"8-K","filed_at":"2024-08-27T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Harvard Apparatus Regenerative Technology appoints StellarS Capital CEO Mao Zhang to board","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Mao Zhang, Founder & CEO of multi-billion-dollar alternative asset manager StellarS Capital, appointed as independent Class I director effective Aug 26, 2024.","Mr. Zhang will receive $25,000 stock option grant vesting quarterly over one year; standard non-employee director compensation ($20k cash + $25k options annually).","Mr. Zhang has over 15 years financial markets experience; previously led Magnetar Capital's Asian business."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":23030772.999999996,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":207788,"accession_number":"0001493152-24-033401","cik":1563665,"company_name":"Harvard Apparatus Regenerative Technology, Inc.","ticker":"HRGN","form_type":"8-K","filed_at":"2024-08-21T23:59:59+00:00","items":["1.01","3.02","9.01"],"status":"ready","headline":"Harvard Apparatus raises $5.0M via private placement of 1.39M shares at $3.60/share","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Sold 1,388,888 shares to Stellars Capital at $3.60/share for approx $5.0 million.","Company must add one board member designated by investor and seek declassification of board and allow special meetings by 35% holders.","Shares issued in unregistered private placement under Section 4(a)(2) and Rule 506."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":23030772.999999996,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":225266,"accession_number":"0001493152-24-024931","cik":1563665,"company_name":"Harvard Apparatus Regenerative Technology, Inc.","ticker":"HRGN","form_type":"8-K","filed_at":"2024-06-24T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Shareholders elect three directors, ratify auditor, and approve executive compensation at 2024 annual meeting","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["David Green, Ting Li, and Ronald Packard elected as Class II directors for three-year terms.","Ratification of Marcum LLP as independent auditor for FY 2024 passed with 9,738,743 votes for.","Non-binding advisory approval of named executive officer compensation passed with 8,033,183 votes for.","Broker non-votes on director election totaled 1,695,472 shares."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":23030772.999999996,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":225265,"accession_number":"0001493152-24-015052","cik":1563665,"company_name":"Harvard Apparatus Regenerative Technology, Inc.","ticker":"HRGN","form_type":"8-K","filed_at":"2024-04-17T23:59:59+00:00","items":["1.01","3.02","9.01"],"status":"ready","headline":"Harvard Apparatus Regenerative Technology raises $1.5M in private placement of 367,767 shares at $4.03/share","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Aggregate purchase price of $1.5 million for 367,767 shares at $4.03 per share in a private placement.","Shares sold exempt from registration under Section 4(a)(2) and Rule 506 of the Securities Act.","Shares to be fully paid, non-assessable, and free of liens upon issuance.","Securities Purchase Agreement includes customary representations, warranties, and covenants."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":23030772.999999996,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}